001     153345
005     20210129213726.0
024 7 _ |a 10.1016/j.ophtha.2013.10.047
|2 doi
024 7 _ |a WOS:000333808100022
|2 WOS
024 7 _ |a altmetric:21823425
|2 altmetric
024 7 _ |a pmid:24365177
|2 pmid
037 _ _ |a FZJ-2014-02977
082 _ _ |a 610
100 1 _ |a Hermann, M. M.
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to Ranibizumab treatment in age-related macular degeneration.
260 _ _ |a Amsterdam [u.a.]
|c 2014
|b Elsevier
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1399273551_3027
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
536 _ _ |a 333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)
|0 G:(DE-HGF)POF2-333
|c POF2-333
|f POF II
|x 0
536 _ _ |a 89572 - (Dys-)function and Plasticity (POF2-89572)
|0 G:(DE-HGF)POF2-89572
|c POF2-89572
|x 1
|f POF II T
700 1 _ |a van Asten, F.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Muether, P. S.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Smailhodzic, D.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Lichtner, P.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Hoyng, C. B.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Kirchhof, B.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Grefkes, C.
|0 P:(DE-Juel1)161406
|b 7
700 1 _ |a den Hollander, A. L.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Fauser, S.
|0 P:(DE-HGF)0
|b 9
|e Corresponding Author
773 _ _ |a 10.1016/j.ophtha.2013.10.047
|0 PERI:(DE-600)2015287-5
|n 4
|p 905 - 910
|t Ophthalmology
|v 121
|y 2014
|x 0161-6420
909 C O |o oai:juser.fz-juelich.de:153345
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)161406
913 2 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Funktion und Dysfunktion des Nervensystems
|1 G:(DE-HGF)POF2-330
|0 G:(DE-HGF)POF2-333
|2 G:(DE-HGF)POF2-300
|v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
913 1 _ |a DE-HGF
|0 G:(DE-HGF)POF2-89572
|v (Dys-)function and Plasticity
|x 1
|4 G:(DE-HGF)POF
|1 G:(DE-HGF)POF3-890
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-800
|b Programmungebundene Forschung
|l ohne Programm
914 1 _ |y 2014
915 _ _ |a Peer review unknown
|0 StatID:(DE-HGF)0040
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21